The invention concerns a compound of formula (Ia) or (Ib) wherein R1 is hydrogen or a methyl group; R2 is an unsubstituted or substituted alkyl group; R3 is an aryl group or a heteroaryl group, optionally substituted by one or more groups selected from halogen, alkyl or alkoxy; and, in Formula (Ia), X is CH or N and Y is NH, S or O, or, in Formula (Ib), X is NH, S or O and Y is CH or N. The invention further concerns a method of synthesizing the inventive compound, a composition comprising the inventive compound or a pharmaceutically acceptable salt thereof and bedaquiline (BDQ), an analogue of bedaquiline (BDQ) or a mixture thereof, and the use of said composition or compound for the treatment of tuberculosis.
该发明涉及一种化合物,其
化学式为(Ia)或(Ib),其中R1为氢或甲基基团;R2为未取代或取代的烷基基团;R3为芳基或杂环芳基,可选择地被卤素、烷基或烷氧基中的一个或多个基团取代;在
化学式(Ia)中,X为CH或N,Y为NH、S或O;或在
化学式(Ib)中,X为NH、S或O,Y为CH或N。该发明还涉及一种合成该创新化合物的方法,包括该创新化合物或其药学上可接受的盐以及贝达替林(BDQ)、贝达替林(BDQ)的类似物或二者混合物的组合物,以及使用该组合物或化合物用于治疗结核病。